{"id":"W2898330783","doi":"10.1093/annonc/mdy282.085","title":"Outcomes by baseline alpha-fetoprotein (AFP) levels in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in previously treated advanced hepatocellular carcinoma (HCC)","year":2018,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Sorafenib; Hepatocellular carcinoma; Internal medicine; Gastroenterology; Placebo; Cabozantinib; Progression-free survival; Overall survival; Cancer; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002028163,0.0009264224,0.001731379,0.0003007901,0.0003635204,0.001033348,0.0004196355,0.0008935601,0.00168923],"category_scores_gemma":[0.001737232,0.0004068561,0.001506629,0.0003857033,0.0007560895,0.000553968,0.0003028475,0.001928787,0.0002274767],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008642384,"about_ca_system_score_gemma":0.001070487,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009131864,"about_ca_topic_score_gemma":0.001873469,"domain_scores_codex":[0.9994004,0.0003515923,0.0000457629,0.00007195657,0.00004477384,0.00008550752],"domain_scores_gemma":[0.9990471,0.0002463673,0.0002693496,0.00004975293,0.00004939569,0.0003379229],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.980112,0.003205263,0.004025886,0.0001783563,0.0007120693,0.00004479869,0.00004046456,0.0003127159,0.00198388,0.00003496023,0.0003746848,0.008974981],"study_design_scores_gemma":[0.7757323,0.1919668,0.02644977,0.00007096347,0.001791328,0.0001603031,0.00006815722,0.001511124,0.001221652,0.0002562226,0.0007471985,0.00002416668],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961334,0.002491735,0.0001007914,0.0002789104,0.0001175804,0.0002370997,0.0001865201,0.00001488805,0.0004391656],"genre_scores_gemma":[0.9976168,0.0009486323,0.0001403133,0.0002285334,0.0001471106,0.0003164867,0.0002448294,0.000004596434,0.0003527781],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002028163,"threshold_uncertainty_score":0.01072609,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.17382696279746,"score_gpt":0.3932074671785705,"score_spread":0.2193805043811104,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}